Search the Archive

AIDS / AZT #555307

NBC Evening News for Monday, Mar 23, 1987
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio: Tom Brokaw) Report introduced.

(NYC: Robert Bazell) Burroughs Wellcome Company's effort to control distribution of experimental drug AZT to certain AIDS patients examined; scenes shown. [AIDS patient Gary STARLIPER - attributes his continued existence to AZT.] [Burroughs spokesperson Paul DRYER - refuses to explain how company arrived at drug's cost to patients.] [Fin. analyst Jonathan GELLES - expects company to realize maj. profit in short period of time.] [AIDS patient Archie HARRISON - comments on cost.]

Reporter(s):
Bazell, Robert;
Brokaw, Tom
Duration:
00:02:10

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.